Sage Journals: Discover world-class research

Retricted access

Research article

First published 1998-10

Acquired Von Willebrand Factor Abnormalities in Adults with Congenital Heart Disease: Dependence Upon Cardiopulmonary Pathophysiological Subtype

Mary C. Territo, Joseph K. Perloff, Michael H. Rosove [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 1995-09

Von Willebrand Factor Antigen and Factor XI Activity Levels As Predictors of Bleeding Tendency in Israeli Patients with Von Willebrand's Disease

Benjamin Brenner, Tamar Stemberg, Arieh Laor [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 1995-09

Coagulation and Fibrinolysis During the First Year of Immunosuppressive Treatment in Renal Transplantation: Correspondence Between Hypercoagulable State and Steroid Therapy

Giovanni Maurizio Patrassi, Maria Teresa Sartori, Paolo Rigotti [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 1997-04

Laboratory Assessment of von Willebrand Factor: Altered Interpretation of Laboratory Data,and Altered Diagnosis of von Willebrand's Disease

Emmanuel J. Favaloro, Pirooz A. Mehrabani, Jerry Koutts

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 1998-04

Plasminogen Activator Inhibitor Type-1 (PAI-1) Levels Are Decreased in NIDDM Patients treated with Insulin

Peter Galajda, Emil Martinka, Ján Staško [...]

Clinical and Applied Thrombosis/Hemostasis

Free access

Research article

First published 1999-01

Elevated Plasma Vascular Endothelial Cell Growth Factor and Thrombomodulin in Juvenile Diabetic Patients

Margaret McLaren, Tarik A. Elhadd, Stephen A. Greene [...]

Clinical and Applied Thrombosis/Hemostasis

Retricted access

Research article

First published 1997-10

Concept and Clinical Application of Platelet Glycoprotein IIb/IIIa Inhibition with Abciximab (c7E3 Fab;ReoPro) for the Prevention of Acute Ischemic Syndromes

H. Vernon Anderson, Robert E. Jordan, Harlan F. Weisman

Clinical and Applied Thrombosis/Hemostasis

Search results

Acquired Von Willebrand Factor Abnormalities in Adults with Congenital Heart Disease: Dependence Upon Cardiopulmonary Pathophysiological Subtype

Von Willebrand Factor Antigen and Factor XI Activity Levels As Predictors of Bleeding Tendency in Israeli Patients with Von Willebrand's Disease

Coagulation and Fibrinolysis During the First Year of Immunosuppressive Treatment in Renal Transplantation: Correspondence Between Hypercoagulable State and Steroid Therapy

Laboratory Assessment of von Willebrand Factor: Altered Interpretation of Laboratory Data,and Altered Diagnosis of von Willebrand's Disease

Plasminogen Activator Inhibitor Type-1 (PAI-1) Levels Are Decreased in NIDDM Patients treated with Insulin

Elevated Plasma Vascular Endothelial Cell Growth Factor and Thrombomodulin in Juvenile Diabetic Patients

Concept and Clinical Application of Platelet Glycoprotein IIb/IIIa Inhibition with Abciximab (c7E3 Fab;ReoPro) for the Prevention of Acute Ischemic Syndromes